CHICAGO, May 27 /PRNewswire/ --Celsis International, the global leader in rapid microbial detection, announced it has recently updated its Drug Master Files with the U.S. Food & Drug Administration ...

Celsis products and services deliver substantial time and cost savings to major pharmaceutical and consumer product companies while ensuring product quality and safety for consumers. Its customers ...

Eurofins Lancaster Laboratories and Celsis International Ltd. have announced that they have entered into a collaboration through which Eurofins Lancaster Laboratories will provide contract rapid ...

CHICAGO--(BUSINESS WIRE)--Celsis In Vitro Technologies Inc. (Celsis IVT), a division of the global life sciences company Celsis International plc, today announced the availability of Celsis InVitroCYP ...

AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis ...

Celsis of the UK has posted a healthy set of results for the first half of the year ended September 30 which show that operating profits climbed 19% to $4.6 million while revenues leapt 31% to $26.3 ...

Celsis deploys ATP bioluminescence to accelerate microbial detection in pharmaceutical manufacturing. Detecting microbial contamination throughout the manufacturing process is an important ...

WILMINGTON, N.C.--(BUSINESS WIRE)--AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services ...

Celsis, the global leader in rapid microbial testing systems for industry, today introduced the Celsis Accel system, the most robust and easiest-to-use rapid microbial screening system for small and ...

Charles Rivers strengthens its endotoxin testing and bacterial identification detection capabilities with the addition of Celsis’ products. Charles River announced on July 9, 2015 that it is acquiring ...

Charles River Laboratories International said today it plans to acquire Celsis International for $212 million cash, in a deal designed to strengthen the buyer’s ability to carry out rapid quality ...

Charles River Laboratories International, Inc. has announced that it has entered into a definitive agreement to acquire Celsis International Ltd. for $212 million in cash, subject to customary closing ...